Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

The prevalence of familial multiple sclerosis in saskatoon, Saskatchewan.
6-Mercaptopurine attenuates tumor necrosis factor-α production in microglia through Nur77-mediated transrepression and PI3K/Akt/mTOR signaling-mediated translational regulation.
The clinical relevance of force platform measures in multiple sclerosis: a review.
On the estimation and correction of bias in local atrophy estimations using example atrophy simulations.
The STAR Study: A Real-World, International, Observational Study of the Safety and Tolerability of, and Adherence to, Serum-Free Subcutaneous Interferon β-1a in Patients With Relapsing Multiple Sclerosis.
A nexus between lipids and multiple sclerosis?
PET imaging of glucose metabolism, neuroinflammation and demyelination in the lysolecithin rat model for multiple sclerosis.
Relationship between Working Hours and Power of Attention, Memory, Fatigue, Depression and Self-Efficacy One Year after Diagnosis of Clinically Isolated Syndrome and Relapsing Remitting Multiple Sclerosis.
Higher macular volume in patients with MS receiving fingolimod: Positive outcome or side effect?
Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
Essential oil from Pterodon emarginatus seeds ameliorates experimental autoimmune encephalomyelitis by modulating Th1/Treg cell balance.
Neuroprotection in Experimental Autoimmune Encephalomyelitis and Progressive Multiple Sclerosis by Cannabis-Based Cannabinoids.
[NMO Spectrum Disorders and Anti AQP4 Antibody].
Amelioration of LPS-Induced Inflammation Response in Microglia by AMPK Activation.
Neurobehavioral disorders.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Genetic aspects of vitamin D receptor and metabolism in relation to the risk of multiple sclerosis.
Targeting IL-10 in Auto-immune Diseases.
International Pediatric MS Study Group Clinical Trials Summit: Meeting report.
Inhibition of delta-like ligand 4 decreases Th1/Th17 response in a mouse model of multiple sclerosis.
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner.
Sphingosine 1-phosphate receptor 1 agonists: a patent review (2013-2015).
Human glial chimeric mice reveal astrocytic dependence of JC virus infection.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
Therapeutic compliance of first line disease-modifying therapies in patients with multiple sclerosis. COMPLIANCE Study.

Pages